Oryzon Genomics (MEX:ORYN) Interest Expense: MXN-5.78 Mil (TTM As of Mar. 2026)


MEX:ORYN Oryzon Genomics SA MEX:ORYN
31 GF Score
Price MXN48.59
View Full Analysis

What is Oryzon Genomics Interest Expense?

Oryzon Genomics MEX:ORYN 31 Interest Expense is MXN-5.78 Mil as of Mar. 2026. GuruFocus rates MEX:ORYN with a GF Score™ of 31/100.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Oryzon Genomics's interest expense for the three months ended in Mar. 2026 was MXN 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was MXN-5.78 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Oryzon Genomics's Operating Income for the three months ended in Mar. 2026 was MXN -120.21 Mil. Oryzon Genomics's Interest Expense for the three months ended in Mar. 2026 was MXN 0.00 Mil. Oryzon Genomics has no long-term debt (1). The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Oryzon Genomics  (MEX:ORYN) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Oryzon Genomics's Interest Expense for the three months ended in Mar. 2026 was MXN0.00 Mil. Its Operating Income for the three months ended in Mar. 2026 was MXN-120.21 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was MXN0.00 Mil.

Oryzon Genomics's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Oryzon Genomics had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Oryzon Genomics Interest Expense Historical Data

* Premium members only.

The historical data trend for Oryzon Genomics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oryzon Genomics Interest Expense Chart

Oryzon Genomics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.59 -23.40 -35.53 -26.61 -12.87

Oryzon Genomics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -5.78 0.00
MEX:ORYN
31GF Score
Oryzon Genomics SA MEX:ORYN
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oryzon Genomics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-5.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of MXN-5.78 Mil mean?
Oryzon Genomics (MEX:ORYN) has a Interest Expense of MXN-5.78 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Oryzon Genomics and its competitors.
Is Oryzon Genomics' Interest Expense too high?
Oryzon Genomics' current Interest Expense is MXN-5.78 Mil. Overall, Oryzon Genomics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Oryzon Genomics' Interest Expense compare to VRTX and REGN?
Oryzon Genomics' Interest Expense of MXN-5.78 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Oryzon Genomics and its competitors. Oryzon Genomics's current Interest Expense is MXN-5.78 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oryzon Genomics stock overvalued right now?
Oryzon Genomics (MEX:ORYN) has a current Interest Expense of MXN-5.78 Mil. The current Interest Expense is MXN-5.78 Mil. Oryzon Genomics' overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Oryzon Genomics (MEX:ORYN), the current Interest Expense is MXN-5.78 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oryzon Genomics Business Description

Address Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.
31GF Score

Get the complete analysis for MEX:ORYN

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN48.59
Price